Niaz, Saghar
Kirwan, Chris
Clayton, Natasha
Mercuri, Mathew
de Wit, Kerstin http://orcid.org/0000-0003-2763-6474
Funding for this research was provided by:
Bayer
Article History
Received: 14 October 2020
Accepted: 28 November 2020
First Online: 20 January 2021
Compliance with ethical standards
:
: Bayer manufacture rivaroxaban which is an anticoagulant used in the prevention of stroke for patients with atrial fibrillation.